| Financial Year |
March 31 2023 |
| Monetary Funds |
1,270,111,421.68 |
| Held-for-trading Financial Assets |
110,618,009.43 |
| Notes Receivable |
-- |
| Accounts Receivable |
241,188,804.94 |
| Advances to Suppliers |
85,507,313.95 |
| Other Receivables |
34,260,329.44 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
973,736,680.29 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
35,243,372.30 |
| Total Current Assets |
2,750,665,932.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
388,983,125.76 |
| Under-construction Projects |
2,097,169.23 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
116,862,307.42 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
28,863,003.09 |
| Deferred Income Tax Assets |
72,670,360.51 |
| Other Non-Current Assets |
216,540.00 |
| Sub-Total of Non-Current Assets |
698,080,777.86 |
| Total Assets |
3,448,746,709.89 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
233,161,921.95 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
51,716,430.34 |
| Taxes Payable |
51,914,261.51 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
103,436,539.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
35,766,320.25 |
| Other Current Liabilities |
28,681,345.78 |
| Sub-Total of Current Liabilities |
528,639,648.28 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
168,042.77 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
82,866,851.73 |
| Total Liabilities |
611,506,500.01 |
| Paid-In Capital(Or Share Stock) |
266,670,000.00 |
| Capital Surplus |
895,170,906.68 |
| Surplus Reserve |
133,435,119.74 |
| LESS:Treasury Stock |
51,736,494.86 |
| Undistributed Profits |
1,593,700,678.32 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,837,240,209.88 |
| Owner's Equity（Stockholder's Equity） |
2,837,240,209.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,448,746,709.89 |
